Treatment

THEO-260 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
Trial of THEO-260 in Ovarian Cancer Patients
This study is testing a new treatment, THEO-260, for advanced ovarian cancer. It's looking for a safe dose and early signs that it can shrink tumours. Only women aged 18 and over with certain types of ovarian cancer who haven't responded to previous treatments can take part.
For: Ovarian Cancer
Spain · United Kingdom